Doctors Revision

Neurological System

Epilepsy

A chronic neurological condition characterized by recurrent, unprovoked seizures, which are caused by abnormal electrical discharges in the brain. Epilepsy can manifest as convulsive (e.g., tonic-clonic) or non-convulsive seizures.

Also known as: Seizure Disorder, Fits

Open in the interactive guide
On this page

Referral and warning signs

When to refer

Refer to specialist (H/RR/NR) if: Diagnosis uncertain. Seizures difficult to classify. Failure of two appropriate AED monotherapies. Suspicion of underlying structural lesion (tumor, etc.). Non-convulsive epilepsy suspected. Pregnant women with epilepsy. Status epilepticus unresponsive to initial treatment.

Red flags

  • Status epilepticus (seizure >5-30 mins or recurrent without recovery)
  • First seizure in adulthood
  • Focal neurological deficit post-seizure (Todd's paresis) that persists
  • Seizure associated with fever and neck stiffness (suspect meningitis)
  • Seizure associated with head trauma
  • Progressive worsening of seizures or neurological status

Signs and symptoms

  • Recurrent seizures (at least 2 unprovoked seizures >24h apart or one unprovoked seizure with high risk of recurrence).
  • Symptoms vary by seizure type:
  • Generalized Tonic-Clonic (Grand Mal): Aura (optional warning), sharp cry, loss of consciousness, fall, tonic muscle contraction (rigidity), followed by clonic jerking movements, potential incontinence (urine/faeces), tongue biting, frothing at mouth, post-ictal sleep/confusion.
  • Absence (Petit Mal): Brief loss of consciousness (5-10 sec) with retained posture, vacant stare, cessation of activity, resumes previous activity afterward, may occur multiple times daily (mainly children).
  • Atonic Seizures (Drop Attacks): Sudden loss of muscle tone causing collapse, brief duration, consciousness may be maintained.
  • Tonic Seizures: Sudden stiffening of muscles.
  • Myoclonic Seizures: Brief, shock-like muscle jerks, usually limbs, may involve whole body.
  • Focal Seizures (Simple): Alertness maintained, abnormal sensory (aura-like feelings, strange taste/smell), motor (jerking limb), psychic (déjà vu), or autonomic (sweating, flushing, nausea) manifestations.
  • Focal Seizures (Complex Partial): Altered awareness/consciousness, confusion, repetitive automatic movements (automatisms, e.g., lip-smacking, fumbling).

Risk factors

  • Genetic predisposition
  • Congenital brain malformations
  • Birth asphyxia
  • Brain tumors
  • Brain infections (meningitis, encephalitis, cysticercosis)
  • Head trauma (acute or past)
  • Stroke
  • Metabolic disorders
  • Idiopathic (no specific cause identified)

Diagnosis

Clinical assessment

Diagnosis based on history of characteristic recurrent seizures (detailed description from patient/witness is crucial). Requires excluding provoked seizures (e.g., due to fever, acute illness, metabolic disturbance, toxins). Consider epilepsy if ≥2 unprovoked seizures.

Investigations

  • Complete medical and mental health assessment.
  • Electroencephalogram (EEG): Useful especially for absence and focal seizures, but a normal EEG does not exclude epilepsy. (RR/NR level).
  • Neuroimaging (CT/MRI brain): To look for structural causes (tumors, stroke, malformations) - often at H/RR/NR level.
  • Blood tests (glucose, electrolytes, calcium, renal/liver function) to rule out metabolic causes or assess for comorbidities/drug effects.
  • Lumbar puncture if infection suspected.

Diagnostic criteria

Clinical diagnosis based on history of at least two unprovoked seizures occurring more than 24 hours apart, or one unprovoked seizure with clinical/EEG/imaging findings indicating a high probability of recurrence. Exclude acute symptomatic seizures.

Management

Non-pharmacological management

  • First Aid for Acute Seizure: Ensure safety (protect from injury, move away from danger like fire), DO NOT restrain, DO NOT put anything in mouth. Place in recovery position (on side) after convulsion stops if unconscious. Stay with the person. Seek help if seizure prolonged.
  • Psychosocial support for patient and family.
  • Health education about epilepsy, seizure triggers, medication adherence, safety precautions (e.g., swimming, driving restrictions).
  • Address associated comorbidities (e.g., intellectual disability, behavioral problems).

Pharmacological treatment

  • Status Epilepticus (Seizure >5-30 min or multiple seizures without recovery): MEDICAL EMERGENCY. Ensure ABCs. Check blood glucose (give IV Dextrose if low/unknown - Adult: 50% 1ml/kg; Child: 10% 5ml/kg). Give IV Diazepam 10mg slow IV (Child: 0.2mg/kg IV) OR Rectal Diazepam 10mg (Child: 0.5mg/kg rectal). Repeat after 5-10 min if seizure persists. If unresponsive: Give IV Phenobarbital 10-15mg/kg slow IV infusion (monitor BP/respiration closely) OR IV Phenytoin 15-18mg/kg slow IV infusion (use good IV line, monitor ECG/BP). Refer urgently if status persists.
  • Chronic Epilepsy (Long-term management): Start with single Anti-Epileptic Drug (AED), low dose, titrate slowly. Aim for lowest effective dose to control seizures. If first AED fails, switch to another monotherapy. If two monotherapies fail, refer to specialist (H/RR). Consider stopping AEDs gradually after 2 years seizure-free (discuss risks/benefits).
  • Choice of AED (Examples based on UCG):
  • - Generalized Tonic-Clonic/Focal: Carbamazepine (Adult: start 100-200mg/d, maint 400-1400mg/d; Child: start 5mg/kg/d, maint 10-20mg/kg/d, divided doses) OR Phenobarbital (Adult: start 1mg/kg/d, maint up to 3mg/kg/d; Child: start 2mg/kg/d, maint up to 6mg/kg/d, once daily PM). Valproate is alternative for >2yrs. Phenytoin also option (Adult: start 150-200mg/d, maint 200-400mg/d; Child: start 3-4mg/kg/d, maint 3-8mg/kg/d).
  • - Absence Seizures: Valproate or Ethosuximide (Child >6y: start 500mg/d, usual 1-1.5g/d; Child <6y: start 250mg/d, usual 20-40mg/kg/d, divided doses).
  • - Caution: Avoid phenobarbital/phenytoin in children with intellectual/behavioral issues (use Carbamazepine/Valproate). Refer pregnant women with epilepsy to specialist.
  • Follow specific Ugandan treatment algorithms/guidelines.

Monitoring

Monitor seizure frequency, type, duration. Monitor for AED side effects (drowsiness, rash, ataxia, gum hyperplasia, blood abnormalities - specific to drug). Follow up monthly until stable, then every 3 months. Monitor adherence. Consider AED levels if poor control or toxicity suspected (often specialist level).

Complications

  • Status epilepticus
  • Injury during seizures (falls, burns, drowning)
  • Sudden Unexpected Death in Epilepsy (SUDEP)
  • Cognitive impairment
  • Psychosocial issues (stigma, depression, anxiety)
  • Side effects of AEDs

Prevention

  • Good antenatal care and delivery practices (prevent birth asphyxia).
  • Prevention and prompt treatment of brain infections (meningitis, cysticercosis).
  • Head injury prevention.
  • Management of risk factors like stroke.
  • Adherence to AEDs to prevent breakthrough seizures.

Patient education

  • Explain epilepsy is a manageable condition.
  • Teach seizure first aid to family/carers.
  • Stress importance of medication adherence (not stopping abruptly).
  • Discuss potential triggers and lifestyle modifications.
  • Advise on safety precautions (e.g., avoid heights, open fires, swimming alone).
  • Address stigma and provide psychosocial support.
  • Educate about side effects and when to report them.

Uganda-specific notes

Neurocysticercosis is a common cause of epilepsy in Uganda. Ensure availability of first-line AEDs (Phenobarbital, Carbamazepine, Phenytoin) at lower levels for refills. Specialist assessment (EEG, imaging) often limited to H/RR/NR levels. High level of stigma associated with epilepsy.

References

  • Uganda Clinical Guidelines (UCG) 2023

    Chapter 9, Section 9.1.1

Scroll to Top